We describe the various molecular and cellular pathways that lead to early and delayed loss of residual hearing after cochlear implantation.
Methods:
We performed a systematic review using the Medline database with the key words cochlear implant, residual hearing, inflammation, apoptosis, and necrosis.
Results:
The mechanisms underlying the loss of residual hearing after cochlear implantation are multiple. Early hearing loss may be provoked by the surgical access to the inner ear spaces and by trauma caused by insertion of the electrode array. After the initial trauma, an acute inflammatory response promotes elevated levels of cytokines and reactive oxygen species, which in turn promote sensory cell loss by apoptosis, necrosis, and necrosis-like programmed cell death. Treatments that counteract such an inflammatory reaction, production of reactive oxygen species, and apoptosis are effective at preventing hair cell degeneration. However, delayed hearing loss appears to be a consequence of chronic inflammation with development of fibrotic tissue. The mechanisms that lead to fibrosis are poorly understood, and standard anti-inflammatory drugs are insufficient for preventing its development.
Conclusions:
Cochlear implantation is followed by an inflammatory response involving several pathways that lead to either short-term or long-term sensory hair cell degeneration. Future studies should focus on revealing the precise molecular mechanisms induced by cochlear implantation to allow the discovery of new targets for the effective prevention and treatment of loss of residual hearing.
DormanMFGiffordRHSpahrAJMcKarnsSA. The benefits of combining acoustic and electric stimulation for the recognition of speech, voice and melodies. Audiol Neurootol2008;13:105–12.
2.
TurnerCWReissLAGantzBJ. Combined acoustic and electric hearing: Preserving residual acoustic hearing. Hear Res2008;242:164–71.
3.
von IlbergCKieferJTilleinJ. Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL J Otorhinolaryngol Relat Spec1999;61:334–40.
4.
ZengFG. Trends in cochlear implants. Trends Amplif2004;8:1–34.
5.
LuetjeCMThedingerBSBucklerLRDawsonKLLisbonaKL. Hybrid cochlear implantation: Clinical results and critical review in 13 cases. Otol Neurotol2007;28:473–8.
6.
RolandPSWrightCGIsaacsonB. Cochlear implant electrode insertion: The round window revisited. Laryngoscope2007;117:1397–402.
7.
Addams-WilliamsJMunaweeraLColemanBShepherdRBackhouseS. Cochlear implant electrode insertion: In defence of cochleostomy and factors against the round window membrane approach. Cochlear Implants Int2011;12 (suppl 2):S36–S39.
8.
PauHWJustTBornitzMLasurashvilliNZahnertT. Noise exposure of the inner ear during drilling a cochleostomy for cochlear implantation. Laryngoscope2007;117:535–40.
9.
AdunkaORoushPGroseJMacphersonCBuchmanCA. Monitoring of cochlear function during cochlear implantation. Laryngoscope2006;116:1017–20.
10.
RadeloffAUnkelbachMHTilleinJ. Impact of intrascalar blood on hearing. Laryngoscope2007;117:58–62.
SkarzyńskiHLorensAPiotrowskaAPodskarbi-FayetteR. Results of partial deafness cochlear implantation using various electrode designs. Audiol Neurootol2009;14 (suppl 1):39–45.
13.
BalkanyTJConnellSSHodgesAV. Conservation of residual acoustic hearing after cochlear implantation. Otol Neurotol2006;27:1083–8.
14.
FraysseBMacíasARSterkersO. Residual hearing conservation and electroacoustic stimulation with the Nucleus 24 Contour Advance cochlear implant. Otol Neurotol2006;27:624–33.
15.
GantzBJTurnerCGfellerKE. Acoustic plus electric speech processing: Preliminary results of a multicenter clinical trial of the Iowa/Nucleus Hybrid implant. Audiol Neurootol2006;11 (suppl 1):63–8.
16.
GstoettnerWKHelbigSMaierNKieferJRadeloffAAdunkaOF. Ipsilateral electric acoustic stimulation of the auditory system: Results of long-term hearing preservation. Audiol Neurootol2006;11 (suppl 1):49–56.
17.
KieferJGstoettnerWBaumgartnerW. Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol2004;124:272–80.
18.
DinhCTVan De WaterTR. Blocking pro-cell-death signal pathways to conserve hearing. Audiol Neurootol2009;14:383–92.
19.
EshraghiAA. Prevention of cochlear implant electrode damage. Curr Opin Otolaryngol Head Neck Surg2006;14:323–8.
20.
ArendsMJWyllieAH. Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol1991;32:223–54.
21.
FiersWBeyaertRDeclercqWVandenabeeleP. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene1999;18:7719–30.
22.
LockshinRAZakeriZ. Apoptosis, autophagy, and more. Int J Biochem Cell Biol2004;36:2405–19.
HirschTMarchettiPSusinSA. The apoptosisnecrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene1997;15:1573–81.
25.
BurschW. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ2001;8:569–81.
26.
KitanakaCKuchinoY. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ1999;6:508–15.
27.
LeistMJäätteläM. Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol2001;2:589–98.
28.
ProskuryakovSYKonoplyannikovAGGabaiVL. Necrosis: A specific form of programmed cell death?. Exp Cell Res2003;283:1–16.
29.
Van De WaterTRAbi HachemRNDinhCT. Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: Molecular and genetic mechanisms. Cochlear Implants Int2010;11 (suppl 1):42–55.
30.
DoKBakerKPraetoriusMStaeckerH. A mouse model of implantation trauma. Int Cong Ser2004;1273:167–70.
31.
EastwoodHPinderDJamesD. Permanent and transient effects of locally delivered N-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res2010;259:24–30.
32.
ClarkGMShuteSAShepherdRKCarterTD. Cochlear implantation: Osteoneogenesis, electrode-tissue impedance, and residual hearing. Ann Otol Rhinol Laryngol Suppl1995;104 (suppl 166):40–2.
33.
HughesMLVander WerffKRBrownCJ. A longitudinal study of electrode impedance, the electrically evoked compound action potential, and behavioral measures in Nucleus 24 cochlear implant users. Ear Hear2001;22:471–86.
34.
DiegelmannRFEvansMC. Wound healing: An overview of acute, fibrotic and delayed healing. Front Biosci2004;9:283–9.
35.
UehaSShandFHMatsushimaK. Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis. Front Immunol2012;3:71.
36.
JamesDPEastwoodHRichardsonRTO'LearySJ. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurootol2008;13:86–96.
37.
JiaHVenailFPironJP. Effect of surgical technique on electrode impedance after cochlear implantation. Ann Otol Rhinol Laryngol2011;120:529–34.
38.
ElliottSJLinetonBNiG. Fluid coupling in a discrete model of cochlear mechanics. J Acoust Soc Am2011;130:1441–51.
39.
LeeJEddingtonDKNadolJB. The histopathology of revision cochlear implantation. Audiol Neurootol2011;16:336–46.
40.
EshraghiAAAdilEHeJGravesRBalkanyTJVan De WaterTR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol2007;28:842–9.
41.
BazzoniFBeutlerB. The tumor necrosis factor ligand and receptor families. N Engl J Med1996;334:1717–25.
GauldieJBonniaudPSimePAskKKolbM. TGFbeta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans2007;35:661–4.
44.
HoldGLUntiverosPSaundersKAEl-OmarEM. Role of host genetics in fibrosis. Fibrogenesis Tissue Repair2009;2:6.
45.
LeaskA. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal2008;20:1409–14.
46.
MenardoJTangYLadrechS. Oxidative stress, inflammation, and autophagic stress as the key mechanisms of premature age-related hearing loss in SAMP8 mouse cochlea. Antioxid Redox Signal2012;16:263–74.
47.
DingDJiangHWangPSalviR. Cell death after co-administration of cisplatin and ethacrynic acid. Hear Res2007;226:129–39.
HwangJHChenJCYangSYWangMFChanYC. Expression of tumor necrosis factor-α and interleukin-1β genes in the cochlea and inferior colliculus in salicylate-induced tinnitus. J Neuroinflammation2011;8:30.
50.
MasudaMNagashimaRKanzakiSFujiokaMOgitaKOgawaK. Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation. Brain Res2006;1068:237–47.
51.
SchererEQYangJCanisM. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke2010;41:2618–24.
52.
AggarwalBB. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis2000;59 (suppl 1):i6–i16.
53.
KhanMSzczepekAJHauptHOlzeHMazurekB. Expression of the proinflammatory cytokines in cochlear explant cultures: Influence of normoxia and hypoxia. Neurosci Lett2010;479:249–52.
54.
KomedaMRoesslerBJRaphaelY. The influence of interleukin-1 receptor antagonist transgene on spiral ganglion neurons. Hear Res1999;131:1–10.
55.
NamSI. Interleukin-1beta up-regulates inducible nitric oxide by way of phosphoinositide 3-kinase-dependent in a cochlear cell model. Laryngoscope2006;116:2166–70.
56.
SatohHFiresteinGSBillingsPBHarrisJPKeithleyEM. Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope2002;112:1627–34. [Erratum in Laryngoscope 2003;113:291.]
57.
SoHKimHLeeJH. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol2007;8:338–55.
58.
ViveroRJJosephDEAngeliS. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope2008;118:2028–35.
59.
YeQTilleinJHartmannRGstoettnerWKieferJ. Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear2007;28:361–9.
60.
ChangAEastwoodHSlyDJamesDRichardsonRO'LearyS. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res2009;255:67–72.
61.
PazirandehSLingPROlleroMGordonFBurnsDLBistrianBR. Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: A preliminary study. JPEN J Parenter Enteral Nutr2007;31:511–6.
62.
Op de BeeckKSchachtJVan CampG. Apoptosis in acquired and genetic hearing impairment: The programmed death of the hair cell. Hear Res2011;281:18–27.
63.
WangJPuelJL. From cochlear cell death pathways to new pharmacological therapies. Mini Rev Med Chem2008;8:1006–19.
64.
EshraghiAAHoosienGRamsayS. Inhibition of the JNK signal cascade conserves hearing against electrode insertion trauma-induced loss. Cochlear Implants Int2010;11 (suppl 1):104–9.
65.
WangJRuelJLadrechSBonnyCvan de WaterTRPuelJL. Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals. Mol Pharmacol2007;71:654–66.
66.
WangJVan De WaterTRBonnyCde RibaupierreFPuelJLZineA. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci2003;23:8596–607.
67.
De CeulaerGJohnsonSYpermanM. Long-term evaluation of the effect of intracochlear steroid deposition on electrode impedance in cochlear implant patients. Otol Neurotol2003;24:769–74.
68.
PaascheGTascheCStöverTLesinski-SchiedatALenarzT. The long-term effects of modified electrode surfaces and intracochlear corticosteroids on postoperative impedances in cochlear implant patients. Otol Neurotol2009;30:592–8.
69.
WorsøeLBrandtCTLundSPOstergaardCThomsenJCayé-ThomasenP. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis. Otol Neurotol2010;31:394–403.
70.
YangGSSongHTKeithleyEMHarrisJP. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol2000;21:499–504.
71.
HuangCQTykocinskiMStathopoulosDCowanR. Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation. Cochlear Implants Int2007;8:123–47.
72.
BraunSYeQRadeloffAKieferJGstoettnerWTilleinJ. Protection of inner ear function after cochlear implantation: Compound action potential measurements after local application of glucocorticoids in the guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec2011;73:219–28.
